Ziprasidone vs olanzapine in recent-onset schizophrenia and schizoaffective disorder: results of an 8-week double-blind randomized controlled trial

K.P. Grootens; N.M.J. van Veelen; J. Peuskens; B.G. Sabbe; E. Thys; J.K. Buitelaar; R.J. Verkes; R.S. Kahn

Ziprasidone vs olanzapine in recent-onset schizophrenia and schizoaffective disorder: results of an 8-week double-blind randomized controlled trial

Translated title of the contribution: Ziprasidone vs olanzapine in recent-onset schizophrenia and schizoaffective disorder: results of an 8-week double-blind randomized controlled trial

K.P. Grootens, N.M.J. van Veelen, J. Peuskens, B.G. Sabbe, E. Thys, J.K. Buitelaar, R.J. Verkes, R.S. Kahn

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Ziprasidone vs olanzapine in recent-onset schizophrenia and schizoaffective disorder: results of an 8-week double-blind randomized controlled trial
Original language	Undefined/Unknown
Pages (from-to)	352-361
Number of pages	10
Journal	Schizophrenia Bulletin
Volume	37
Issue number	2
Publication status	Published - 2011

Keywords

Econometric and Statistical Methods: General
Geneeskunde(GENK)
Medical sciences
Bescherming en bevordering van de menselijke gezondheid

Access to Document

http://www.ncbi.nlm.nih.gov/pubmed?term=van%20veelen%20nm%202012

Cite this

Grootens, K. P., van Veelen, N. M. J., Peuskens, J., Sabbe, B. G., Thys, E., Buitelaar, J. K., Verkes, R. J., & Kahn, R. S. (2011). Ziprasidone vs olanzapine in recent-onset schizophrenia and schizoaffective disorder: results of an 8-week double-blind randomized controlled trial. Schizophrenia Bulletin, 37(2), 352-361. http://www.ncbi.nlm.nih.gov/pubmed?term=van%20veelen%20nm%202012

@article{b8db5e2f76ab400bb1aa6740437587e2,

title = "Ziprasidone vs olanzapine in recent-onset schizophrenia and schizoaffective disorder: results of an 8-week double-blind randomized controlled trial",

keywords = "Econometric and Statistical Methods: General, Geneeskunde(GENK), Medical sciences, Bescherming en bevordering van de menselijke gezondheid",

author = "K.P. Grootens and {van Veelen}, N.M.J. and J. Peuskens and B.G. Sabbe and E. Thys and J.K. Buitelaar and R.J. Verkes and R.S. Kahn",

year = "2011",

language = "Undefined/Unknown",

volume = "37",

pages = "352--361",

journal = "Schizophrenia Bulletin",

issn = "0586-7614",

publisher = "Oxford University Press",

number = "2",

}

Grootens, KP, van Veelen, NMJ, Peuskens, J, Sabbe, BG, Thys, E, Buitelaar, JK, Verkes, RJ & Kahn, RS 2011, 'Ziprasidone vs olanzapine in recent-onset schizophrenia and schizoaffective disorder: results of an 8-week double-blind randomized controlled trial', Schizophrenia Bulletin, vol. 37, no. 2, pp. 352-361. <http://www.ncbi.nlm.nih.gov/pubmed?term=van%20veelen%20nm%202012>

TY - JOUR

T1 - Ziprasidone vs olanzapine in recent-onset schizophrenia and schizoaffective disorder: results of an 8-week double-blind randomized controlled trial

AU - Grootens, K.P.

AU - van Veelen, N.M.J.

AU - Peuskens, J.

AU - Sabbe, B.G.

AU - Thys, E.

AU - Buitelaar, J.K.

AU - Verkes, R.J.

AU - Kahn, R.S.

PY - 2011

Y1 - 2011

KW - Econometric and Statistical Methods: General

KW - Geneeskunde(GENK)

KW - Medical sciences

KW - Bescherming en bevordering van de menselijke gezondheid

M3 - Article

SN - 0586-7614

VL - 37

SP - 352

EP - 361

JO - Schizophrenia Bulletin

JF - Schizophrenia Bulletin

IS - 2

ER -